Kiniksa Pharmaceuticals International, plc SEC filings KNSA
Kiniksa Pharmaceuticals International, plc has 776 filings in SEC EDGAR's recent list, going back to Feb 27, 2018. Its latest annual report, Form ARS, was filed on Apr 16, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Oct 27, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Oct 27, 2026 (results of operations). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 10-Q | Quarterly report | Oct 27, 2026 | Sep 30, 2026 |
| 10-Q | Quarterly report | Jul 28, 2026 | Jun 30, 2026 |
| 10-Q | Quarterly report | Apr 28, 2026 | Mar 31, 2026 |
| 10-Q | Quarterly report | Oct 28, 2025 | Sep 30, 2025 |
| 10-Q | Quarterly report | Jul 29, 2025 | Jun 30, 2025 |
| 10-Q | Quarterly report | Apr 29, 2025 | Mar 31, 2025 |
| 10-Q | Quarterly report | Oct 29, 2024 | Sep 30, 2024 |
| 10-Q | Quarterly report | Jul 25, 2024 | Jun 30, 2024 |
| 10-Q | Quarterly report | Apr 25, 2024 | Mar 31, 2024 |
| 10-Q | Quarterly report | Nov 2, 2023 | Sep 30, 2023 |
| 10-Q | Quarterly report | Aug 1, 2023 | Jun 30, 2023 |
| 10-Q | Quarterly report | May 4, 2023 | Mar 31, 2023 |
| 10-Q | Quarterly report | Nov 3, 2022 | Sep 30, 2022 |
| 10-Q | Quarterly report | Aug 4, 2022 | Jun 30, 2022 |
| 10-Q | Quarterly report | May 5, 2022 | Mar 31, 2022 |
| 10-Q | Quarterly report | Nov 4, 2021 | Sep 30, 2021 |
| 10-Q | Quarterly report | Aug 5, 2021 | Jun 30, 2021 |
| 10-Q | Quarterly report | May 6, 2021 | Mar 31, 2021 |
| 10-Q | Quarterly report | Nov 5, 2020 | Sep 30, 2020 |
| 10-Q | Quarterly report | Aug 4, 2020 | Jun 30, 2020 |
| 10-Q | Quarterly report | May 4, 2020 | Mar 31, 2020 |
| 10-Q | Quarterly report | Nov 5, 2019 | Sep 30, 2019 |
| 10-Q | Quarterly report | Aug 13, 2019 | Jun 30, 2019 |
| 10-Q | Quarterly report | May 7, 2019 | Mar 31, 2019 |
| 10-Q | Quarterly report | Nov 6, 2018 | Sep 30, 2018 |
| 10-Q | Quarterly report | Aug 6, 2018 | Jun 30, 2018 |
Showing 26 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- KNSA (Nasdaq)
- Fiscal year ends
- December 31
- Headquarters
- London
- SEC filer status
- Large accelerated filer
- SEC CIK
- 1730430
- Former names
- Kiniksa Pharmaceuticals, Ltd. (until Jun 28, 2024)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.